Treating Hammertoe with A New 3D Implant

Treating Hammertoe with A New 3D Implant

By Manufacturing Technology Insights | Friday, February 01, 2019

The objective of Additive Orthopedics is to integrate advanced manufacturing and biologics in the interests of better results for patients. The company focuses on the use in the global orthopedics market of the patient, technological and cost benefits of additive manufacturing. Additive manufacturing enables them to evolve advanced orthopedic devices with complex geometries with ancient, underlying production processes at a lower price. These devices can also be individually tailored for patients.

Additive Orthopedics has created and patented several innovative designs that are embedded in their current products and future pipelines. These structures are only possible with the use of advanced additive manufacturing. Additive Orthopedics continues to develop innovative technology in order to assist surgeons and their patients with world-renowned orthopedic surgeons and foot, ankle, and toe specialists.

Additive Orthopedics has indicated that it has obtained clearance of FDA510(k) for its patient-specific 3D printing grid plates. The newly cleared devices provide the federal watchdog with information on fractional alignments, stabilizations and fusions, osteotomies, and arthrodesis of small bones in foot and ankle. Additive Orthopedics stated that their patient-specific implants would be the cornerstone of their integrated operational planning system, to be launched later this year.

Many cases of hammertoe have to be rectified by a podiatric operation which means that affected toes are reshaped operatively. In fact, in the United States, more than 1 million people end up having an operation every year to correct their hammertoe. Like any foot surgery, this can often cause a lot of pain and take weeks to recover to get fully mobile again, and it does not guarantee that the problem will be resolved permanently. However, Additive Orthopedics, New Jersey-based manufacturer and developer of an early orthopedic extremity device has announced that a number of patients diagnosed with hammertoe have successful in the treatment of hammertoe with a new 3D implant.

Additive Orthopedics has developed their 3D implant to be manufactured faster, tailored to the patient’s foot, to better correct the chances of the disease. Following successful implant testing, the FDA has cleared the implant and made it available to doctors throughout the country.

Weekly Brief

New Editions